Abstract
The inhibition of scorpion extracts on esophageal cancer and lung adenocarcinoma cells has been reported by previous studies, but the specific anti-tumor efficacy and potential molecular mechanism have not been clarified. In this study, we first modified the optimal enzymolysis and inactivation technology by imitating gastric and intestinal enzyme, and then investigated the antitumor effect of scorpion extracts both in vitro and in vivo. Our results showed that scorpion alcohol extraction with or without enzymolysis and fermentation could inhibit the cell proliferation of esophageal cancer and lung adenocarcinoma, and tumor growth in S180 tumor burden mice. In addition, the SOD activity increased by scorpion extracts, but MDA content decreased. The scorpion alcohol extracts without fermentation and enzymolysis exert inhibitory effect on the growth of esophageal cancer cells, and unenzymolytic fermented extracts have strong inhibitory effect on the growth of lung cancer cells. The scorpion and its extracts may serve as a new therapeutic agent to suppress tumor growth probably by promoting the function of immune organs and enhancing the activity of the immune system.
Keywords: Esophageal cancer, lung cancer, scorpion, therapy.
Graphical Abstract
Current Signal Transduction Therapy
Title:Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Volume: 11 Issue: 1
Author(s): Yixuan Dong, Jihui Wang, Jing Li and Wei Li
Affiliation:
Keywords: Esophageal cancer, lung cancer, scorpion, therapy.
Abstract: The inhibition of scorpion extracts on esophageal cancer and lung adenocarcinoma cells has been reported by previous studies, but the specific anti-tumor efficacy and potential molecular mechanism have not been clarified. In this study, we first modified the optimal enzymolysis and inactivation technology by imitating gastric and intestinal enzyme, and then investigated the antitumor effect of scorpion extracts both in vitro and in vivo. Our results showed that scorpion alcohol extraction with or without enzymolysis and fermentation could inhibit the cell proliferation of esophageal cancer and lung adenocarcinoma, and tumor growth in S180 tumor burden mice. In addition, the SOD activity increased by scorpion extracts, but MDA content decreased. The scorpion alcohol extracts without fermentation and enzymolysis exert inhibitory effect on the growth of esophageal cancer cells, and unenzymolytic fermented extracts have strong inhibitory effect on the growth of lung cancer cells. The scorpion and its extracts may serve as a new therapeutic agent to suppress tumor growth probably by promoting the function of immune organs and enhancing the activity of the immune system.
Export Options
About this article
Cite this article as:
Dong Yixuan, Wang Jihui, Li Jing and Li Wei, Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma, Current Signal Transduction Therapy 2016; 11 (1) . https://dx.doi.org/10.2174/1574362411666160210232741
DOI https://dx.doi.org/10.2174/1574362411666160210232741 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The GABAergic System and the Gastrointestinal Physiopathology
Current Pharmaceutical Design Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Anti-Cancer Agents in Medicinal Chemistry Molecular Aspects of FKBP51 that Enable Melanoma Dissemination
Current Molecular Pharmacology Effects of Alcohol in the Lung
Current Respiratory Medicine Reviews Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Current Cancer Drug Targets Pharmacogenomics of Xenobiotic Metabolizing Enzymes in South American Populations
Current Pharmacogenomics Patent Selections :
Recent Patents on CNS Drug Discovery (Discontinued) Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances
Current Cancer Therapy Reviews Tc-99m Radiolabeled Alendronate Sodium Microemulsion: Characterization and Permeability Studies Across Caco-2 Cells
Current Drug Delivery Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Current Drug Metabolism Chemoprotective and Carcinogenic Effects of tert-Butylhydroquinone and Its Metabolites
Current Drug Metabolism Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions
Current Topics in Medicinal Chemistry Comprehensive Review of Cancer Chemopreventive Agents Evaluated in Experimental Carcinogenesis Models and Clinical Trials
Current Medicinal Chemistry The Synthetic Oleanane Triterpenoid HIMOXOL Induces Autophagy in Breast Cancer Cells via ERK1/2 MAPK Pathway and Beclin-1 Up-regulation
Anti-Cancer Agents in Medicinal Chemistry Epidemiology of Candida albicans Infections and Role of Non-Candidaalbicans Yeasts
Current Drug Targets Evolution of the Strategies for Screening and Identifying Human Tumor Antigens
Current Protein & Peptide Science On the Use of Hydrogels in Cell Encapsulation and Tissue Engineering Systems
Recent Patents on Drug Delivery & Formulation The Tribbles-1 Protein in Humans: Roles and Functions in Health and Disease
Current Molecular Medicine Shaping Tumor Microenvironment for Improving Nanoparticle Delivery
Current Drug Metabolism Evaluation of Angiogenesis with the Expression of VEGF-C and CD34 in Human Colon Cancer
Current Chemical Biology